We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.86T
$524M 2.18%
22,540,900
+576,300
+3% +$12.3M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$4.23T
$369M 1.54%
12,784,785
+364,886
+3% +$9.9M
PFE icon
3
Pfizer
PFE
$158B
$338M 1.41%
12,006,168
+9,927
+0.1% +$283K
AMGN icon
4
Amgen
AMGN
$206B
$333M 1.39%
2,816,064
-35,875
-1% -$4.15M
GILD icon
5
Gilead Sciences
GILD
$182B
$329M 1.37%
3,966,623
+1,463,021
+58% +$114M
XOM icon
6
ExxonMobil
XOM
$679B
$319M 1.33%
3,172,345
+154,273
+5% +$15.6M
ORCL icon
7
Oracle
ORCL
$417B
$302M 1.26%
7,443,305
-279,613
-4% -$11.5M
WFC icon
8
Wells Fargo
WFC
$268B
$296M 1.23%
5,637,418
-384,587
-6% -$19.3M
MSFT icon
9
Microsoft
MSFT
$3.75T
$264M 1.1%
6,341,551
+422,880
+7% +$17.1M
JNJ icon
10
Johnson & Johnson
JNJ
$642B
$220M 0.92%
2,107,062
-67,860
-3% -$6.86M
MRK icon
11
Merck
MRK
$357B
$220M 0.92%
3,985,132
+236,228
+6% +$12.9M
COP icon
12
ConocoPhillips
COP
$164B
$210M 0.87%
2,448,220
+56,432
+2% +$4.4M
HPQ icon
13
HP
HPQ
$30.7B
$208M 0.86%
13,583,107
-723,705
-5% -$10.9M
UNH icon
14
UnitedHealth
UNH
$344B
$198M 0.83%
2,426,760
+72,876
+3% +$5.73M
CNH
15
CNH Industrial
CNH
$22.1B
$195M 0.81%
21,881,428
+970,651
+5% +$9.26M
CVX icon
16
Chevron
CVX
$416B
$191M 0.8%
1,465,637
+38,397
+3% +$4.78M
DB icon
17
Deutsche Bank
DB
$74B
$189M 0.79%
5,990,331
-6,935,415
-54% -$247M
VZ icon
18
Verizon
VZ
$213B
$188M 0.78%
3,851,832
-3,833,893
-50% -$186M
DFS
19
DELISTED
Discover Financial Services
DFS
$182M 0.76%
2,932,626
+20,542
+0.7% +$1.2M
MRO
20
DELISTED
Marathon Oil Corporation
MRO
$181M 0.75%
4,541,183
-94,672
-2% -$3.49M
NOC icon
21
Northrop Grumman
NOC
$74.9B
$181M 0.75%
1,508,940
+13,840
+0.9% +$1.67M
CMCSA icon
22
Comcast
CMCSA
$88.3B
$177M 0.74%
6,590,186
-3,127,532
-32% -$80.4M
BKNG icon
23
Booking.com
BKNG
$132B
$173M 0.72%
3,589,900
+21,025
+0.6% +$1.01M
NSC icon
24
Norfolk Southern
NSC
$71.9B
$172M 0.71%
1,667,646
-44,620
-3% -$4.38M
RTN
25
DELISTED
Raytheon Company
RTN
$171M 0.71%
1,857,676
+59,430
+3% +$5.76M
1
2 3 4 5

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.